Irinotecan-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Irinotecan-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses

Published:2016-08-09 Issue:1 Volume:17 Page:21-28
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Campbell J M,Stephenson M D,Bateman E,Peters M D J,Keefe D M,Bowen J M

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.nature.com/articles/tpj201658.pdf

Reference60 articles.

1. Marsh S, Hoskins JM . Irinotecan pharmacogenomics. Pharmacogenomics 2010; 11: 1003–1010.

2. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000; 355: 1041–1047.

3. Ratain MJ . Irinotecan dosing: does the CPT in CPT-11 stand for "Can't Predict Toxicity"? J Clin Oncol 2002; 20: 7–8.

4. Nakayama G, Tanaka C, Uehara K, Mashita N, Hayashi N, Kobayashi D et al. The impact of dose/time modification in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancer. Cancer Chemother Pharmacol 2014; 73: 847–855.

5. Shiozawa T, Tadokoro J, Fujiki T, Fujino K, Kakihata K, Masatani S et al. Risk factors for severe adverse effects and treatment-related deaths in Japanese patients treated with irinotecan-based chemotherapy: a postmarketing survey. Jpn J Clin Oncol 2013; 43: 483–491.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liposomal irinotecan (HR070803) in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors: a phase 1b dose-escalation and expansion study;Investigational New Drugs;2024-07-22

2. Apigenin Synergizes with Irinotecan in Inducing the Immunogenic Effects in Colorectal Cancer;2024

3. Clinical utility of overviews on adverse events of pharmacological interventions;Systematic Reviews;2023-07-31

4. Transporter and metabolic enzyme-mediated intra-enteric circulation of SN-38, an active metabolite of irinotecan: A new concept;Biochemical and Biophysical Research Communications;2023-07

5. Resistance to TOP-1 Inhibitors: Good Old Drugs Still Can Surprise Us;International Journal of Molecular Sciences;2023-04-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3